Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1160 | 1160 | 1246 | 1060 | 1754 | 2837 |
Fund Return | 16.02% | 16.02% | 24.6% | 1.97% | 11.89% | 10.99% |
Place in category | 29 | 29 | 221 | 264 | 133 | 114 |
% in Category | 7 | 7 | 42 | 54 | 28 | 29 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Oppenheimer Developing Markets Y | 11.11B | 2.12 | -7.74 | 2.12 | ||
Oppenheimer Main Street A | 8.83B | 12.31 | 9.26 | 11.11 | ||
Oppenheimer Developing Markets I | 8.65B | 2.15 | -7.62 | 2.29 | ||
Oppenheimer Global A | 6.15B | 11.06 | 4.92 | 9.29 | ||
Oppenheimer Capital Appreciation A | 4.63B | 15.51 | 9.15 | 12.95 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
T. Rowe Price Mid-Cap Growth I | 12.41B | 8.50 | 4.20 | - | ||
T. Rowe Price Mid-Cap Growth | 12.3B | 8.47 | 4.07 | 11.20 | ||
T. Rowe Price New Horizons I | 11.17B | 6.12 | -3.10 | - | ||
Principal MidCap Institutional | 11.77B | 10.97 | 9.12 | 12.70 | ||
Vanguard Mid-Cap Growth Index Admir | 11.87B | 7.56 | 3.89 | 10.63 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Transdigm | US8936411003 | 2.24 | 1,295.00 | +1.83% | |
MongoDB | US60937P1066 | 2.15 | 362.85 | -0.09% | |
Monolithic | US6098391054 | 2.06 | 707.22 | -0.80% | |
Manhattan Associates | US5627501092 | 1.95 | 210.76 | +0.92% | |
Ares Management | US03990B1017 | 1.88 | 131.91 | -2.03% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review